Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;71(5):559-569.
doi: 10.1016/j.jadohealth.2022.06.015. Epub 2022 Jul 4.

SARS-CoV-2 Seroprevalence: Demographic and Behavioral Factors Associated With Seropositivity Among College Students in a University Setting

Affiliations

SARS-CoV-2 Seroprevalence: Demographic and Behavioral Factors Associated With Seropositivity Among College Students in a University Setting

Karen Diepstra et al. J Adolesc Health. 2022 Nov.

Abstract

Purpose: Examine SARS-CoV-2 seroprevalence and the association of seropositivity with demographic, geographic, and behavioral variables among University of North Carolina Chapel Hill (UNC-CH) undergraduate students enrolled in the fall 2020 semester.

Methods: All UNC-CH undergraduate students were invited to participate in the Heelcheck study; participants were weighted to the UNC-CH undergraduate population using raking methods. We estimate SARS-CoV-2 seroprevalence at study entrance (11/12/2020-12/10/2020) and bivariable associations using log-binomial regression.

Results: SARS-CoV-2 seroprevalence was 7.3% (95% confidence interval (CI): 5.4%-9.2%) at baseline. Compared to students who were living off-campus in the Chapel Hill/Carrboro area (CH) for the Fall 2020 semester (8.6% seroprevalence), students who never returned to CH had lower seroprevalence (1.9%, prevalence ratio (PR), 95% CI: 0.22, 0.06-0.81), whereas, students who started the semester on-campus and moved to off-campus CH housing had 18.9% seroprevalence (PR, 95% CI: 2.21, 1.04-4.72) and students who spent the semester living in a Sorority/Fraternity house had 46.8% seroprevalence (PR, 95% CI: 5.47, 2.62-11.46). Those who predicted they would join an indoor party unmasked had 3.8 times the seroprevalence of those who indicated they would not attend (PR, 95% CI: 3.80, 1.58-9.16). Compared to students who disagreed with the statement "…I am not going to let COVID-19 stop me from having fun…", those who agreed had higher seroprevalence (14.0% vs. 5.7%; (PR, 95% CI: 2.45, 1.13-5.32)).

Discussion: Increased seroprevalence was associated with congregate living and participation (actual or endorsed) in social activities. During pandemics, universities must create safe socializing opportunities while minimizing transmission.

Keywords: COVID-19; Campus life; College life; SARS-CoV-2; Serology; Seroprevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated associations between SARS-CoV-2 seropositivity and demographic/geographic characteristics in the weighted sample. CH: Chapel Hill; Weighted prevalence ratio (PR) estimates and 95% CIs were calculated using log-binomial regression with a robust error variance; PR presented on the log scale; Reference group remains constant until noted; PR not estimated if group had five or fewer individuals and/or zero outcomes (subgroups: Black/African-American, students who were in CH off campus on Aug 10 and then left CH).

References

    1. Reese H., Iuliano A.D., Patel N.N., et al. Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization-United States, February-September 2020. Clin Infect Dis. 2021;72:e1010–e1017. - PMC - PubMed
    1. Boehmer T.K., DeVies J., Caruso E., et al. Changing age distribution of the COVID-19 pandemic - United States, May-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1404–1409. - PMC - PubMed
    1. Salvatore P.P., Sula E., Coyle J.P., et al. Recent increase in COVID-19 cases reported among adults aged 18-22 years - United States, May 31-September 5, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1419–1424. - PMC - PubMed
    1. Walke H.T., Honein M.A., Redfield R.R. Preventing and responding to COVID-19 on college campuses. JAMA. 2020;324:1727–1728. - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2020;384:403–416. - PMC - PubMed

Publication types